{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:17:05Z","timestamp":1782127025954,"version":"3.54.5"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi231486-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The publication of the Antenatal Late Preterm Steroids (ALPS) trial in February 2016 demonstrated that antenatal administration of betamethasone in the late preterm period (between 34 to 36 weeks of gestation) for individuals with a high risk of delivery decreased neonatal respiratory morbidity. National estimates have suggested the trial did change obstetric practice, but little is known if the evidence was adopted uniformly or equitably.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi231486-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess regional variation in the use of late preterm steroids after the publication of the Antenatal Late Preterm Steroids (ALPS) Trial and to understand factors associated with a region\u2019s pace of adoption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi231486-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cross-sectional study used US natality data from February 2015 to October 2017 from hospital referral regions (HRRs) within the US. Inclusion criteria included live-born, nonanomalous, singleton, late preterm (34 to 36 completed weeks of gestation) neonates born to individuals without pregestational diabetes. This study was conducted from November 15, 2022, to January 13, 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi231486-7\">\n                    <jats:title>Main Outcome and Measures<\/jats:title>\n                    <jats:p>\n                      HRRs were categorized as either a slower adopter or faster adopter of antenatal late preterm steroids based on the observed vs expected pace of antenatal steroid adoption in a 1-year period after the trial\u2019s dissemination. Patient and regional factors hypothesized a priori to be associated with the uptake of late preterm steroids were compared between faster and slower adopters. Comparisons were made using Student\n                      <jats:italic>t<\/jats:italic>\n                      test or Wilcoxon rank-sum test, as appropriate. A multivariable logistic regression was constructed to identify factors associated with faster adopter status in the postperiod.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi231486-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 666\u202f097 late preterm births in 282 HRRs. The mean (SD) maternal age in HRRs was 27.9 (1.2) years. The median (IQR) percentage of births by race categories in HRRs for patients identifying as American Indian or Alaskan Native was 0.5% (0.2%-1.3%); Asian or Pacific Islander, 3.0% (1.7%-5.3%); Black, 12.9% (5.1%-29.1%); and White, 78.6% (66.6%-87.0%). The median percentage of births in HRRs to patients of Hispanic ethnicity was 11.2% (6.3%-27.4%). In this study, 136 HRRs (48.2%) were classified as faster adopters and 146 (51.8%) were classified as slower adopters. Faster adopters increased their steroid use by 12.1 percentage points (from 5.9% to 18.0%) compared with a 5.5 percentage point increase (from 3.7% to 9.2%) among slower adopters (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Most examined patient and regional factors were not associated with a region\u2019s pace of adoption, with the exception of the regional prevalence of prior preterm birth (adjusted odds ratio [aOR], 2.04 [95% CI, 1.48-2.82]) and the percentage of deliveries at 34 to 35 weeks of gestation (aOR, 0.68 [95% CI, 0.47-0.99]) compared with 36 weeks.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi231486-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cross-sectional study, there was widespread geographic variation in the adoption of antenatal steroid administration for late preterm births that largely remained unexplained by population factors. These findings should prompt further investigations to barriers to timely or equitable access to new evidence-based practices and guide future dissemination strategies with the goal of more uniform adoption.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.50830","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T11:03:13Z","timestamp":1704798193000},"page":"e2350830","source":"Crossref","is-referenced-by-count":7,"title":["Regional Variation in Antenatal Late Preterm Steroid Use Following the ALPS Trial"],"prefix":"10.1001","volume":"7","author":[{"given":"Taylor S.","family":"Freret","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Biology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gyamfi-Bannerman","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California at San Diego, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali J.","family":"Kaimal","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of South Florida, Tampa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Lorch","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Melamed","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Biology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Clapp","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Biology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"issue":"14","key":"zoi231486r1","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal betamethasone for women at risk for late preterm delivery.","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi231486r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.12702","article-title":"US incidence of late-preterm steroid use and associated neonatal respiratory morbidity after publication of the antenatal late preterm steroids trial, 2015-2017.","volume":"5","author":"Clapp","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"12","key":"zoi231486r3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","article-title":"The answer is 17 years, what is the question: understanding time lags in translational research.","volume":"104","author":"Morris","year":"2011","journal-title":"J R Soc Med"},{"issue":"4","key":"zoi231486r4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/AOG.0000000000004708","article-title":"Geographic variation in apical support procedures for pelvic organ prolapse.","volume":"139","author":"Gerjevic","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"10","key":"zoi231486r5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/COC.0000000000000944","article-title":"Regional variation in access to oncologic care and racial disparities among cervical cancer patients.","volume":"45","author":"Alimena","year":"2022","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"zoi231486r6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10995-012-0945-7","article-title":"Regional variation in late preterm births in North Carolina.","volume":"17","author":"Aliaga","year":"2013","journal-title":"Matern Child Health J"},{"issue":"10","key":"zoi231486r7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/bjo.1994.101.issue-10","article-title":"Variation in obstetric care within and between hospital levels in Finland.","volume":"101","author":"Hemminki","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"issue":"9596","key":"zoi231486r9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"zoi231486r10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ajog.2022.08.029","article-title":"Late-preterm steroid use among individuals with pregestational diabetes mellitus and with twin gestations.","volume":"227","author":"Freret","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"zoi231486r11","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jamapediatrics.2022.3251","article-title":"Antenatal steroid exposure among term newborns.","volume":"176","author":"Freret","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"4","key":"zoi231486r12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1097\/AOG.0000000000001702","article-title":"Practice bulletin No. 171 summary: management of preterm labor.","volume":"128","author":"Practice Bulletin No","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"4","key":"zoi231486r13","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1097\/AOG.0000000000001715","article-title":"Committee opinion No. 677: antenatal corticosteroid therapy for fetal maturation.","volume":"128","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Obstetric Practice","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"2","key":"zoi231486r14","doi-asserted-by":"publisher","first-page":"B13","DOI":"10.1016\/j.ajog.2016.03.013","article-title":"Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery.","volume":"215","author":"Society for Maternal-Fetal Medicine (SMFM) Publications Committee","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"zoi231486r17","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1055\/s-0040-1721717","article-title":"Is Appropriate administration of antenatal corticosteroids associated with maternal race","volume":"39","author":"Ondusko","year":"2022","journal-title":"Am J Perinatol"},{"issue":"9606","key":"zoi231486r19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth.","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"zoi231486r20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3109\/14767058.2011.597899","article-title":"Preterm birth aetiology 2004-2008\u2014maternal factors associated with three phenotypes: spontaneous preterm labour, preterm pre-labour rupture of membranes and medically indicated preterm birth.","volume":"25","author":"Henderson","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"19","key":"zoi231486r21","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.3109\/14767058.2015.1118035","article-title":"Maternal and neonatal epidemiological features in clinical subtypes of preterm birth.","volume":"29","author":"Gimenez","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"8","key":"zoi231486r22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/jpc.v58.8","article-title":"The risk factors of preterm birth: a multicentre case-control survey in China in 2018.","volume":"58","author":"Zhang","year":"2022","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"zoi231486r23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamapediatrics.2019.0032","article-title":"Cost-effectiveness of antenatal corticosteroid therapy vs no therapy in women at risk of late preterm delivery: a secondary analysis of a randomized clinical trial.","volume":"173","author":"Gyamfi-Bannerman","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"8","key":"zoi231486r24","first-page":"1","article-title":"Assessing the quality of medical and health data from the 2003 birth certificate revision: results from New York City.","volume":"68","author":"Gregory","year":"2019","journal-title":"Natl Vital Stat Rep"},{"key":"zoi231486r8","unstructured":"NVSS National Vital Statistics System\u2014birth data. Centers for Disease Control and Prevention. Accessed July 1, 2022. https:\/\/www.cdc.gov\/nchs\/nvss\/births.htm"},{"key":"zoi231486r15","unstructured":"The Center for the Evaluative Clinical Sciences Dartmouth Medical School. The Dartmouth Atlas of Health Care, 1999. American Hospital Association; 1999. Accessed December 4, 2023. https:\/\/data.dartmouthatlas.org\/downloads\/atlases\/99Atlas.pdf"},{"key":"zoi231486r16","unstructured":"Federal information processing system (FIPS) codes for states and counties. Federal Communications Committee. Accessed November 1, 2022. https:\/\/transition.fcc.gov\/oet\/info\/maps\/census\/fips\/fips.txt"},{"key":"zoi231486r18","unstructured":"Area health resource files data downloads. Health Resources and Services Administration. Accessed November 1, 2022. https:\/\/data.hrsa.gov\/data\/download?data=AHRF#AHRF"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2813747\/freret_2024_oi_231486_1703778833.07397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T11:03:18Z","timestamp":1704798198000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2813747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.50830","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.05.25.23290522","asserted-by":"object"}]},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]}}}